Skip to content
case study
CLINICAL CASE IN TRICHOLOGY:
PATIENT WITH DEFICIENT ALOPECIA
ESTRONE DEFICIENCY
Treated with RestaX Woman 30cpr and TriVis AGA Women's Lotion
Dr. Nadia Russo
Medical Surgeon
Specialist in Dermatology and Venereology
PhD in experimental dermatology
Prof. A c. University of Salerno
CLINICAL CASE.
Patient: Female, 22 years old
Diagnosis: Estrone deficient alopecia
Therapy: Restax Donna 30 cps for 3 months, 1 cps daily taken in the evening during dinner, TriVis AGA Women’s Lotion applied after taking the nutraceutical, 15 sprays of lotion every 2 days, massaging until fully absorbed
Presentation of a clinical case with photographic comparison referring to the pre- and post-therapy period. The patient presented a clinical picture of generalized thinning, but particularly evident on the vertex associated with scalp soreness and a general reduction in hair volume, complaining of fine and weak hair, a picture typical of estrone-deficient alopecia.
The therapeutic choice is aimed at the use of Restax Donna 30cps, combined with TriVis AGA Women’s Lotion in order to control the inflammation complained of by the patient and promote anagen.
Share the article on your socials!
Stay up to date*, sign up for our Science Newsletter to receive every article on your email!
You may also be interested in.
-
The use of Ginkgo biloba extract in the treatment of chronic fatigue syndrome -
ON THE USE OF SPECIFIC NUTRACEUTICALS AS ADJUNCTS TO TREATMENTS FOR ADHD -
THEY TALK ABOUT TRIVIS UV ON “THE SKIN” -
ON THE BENEFITS OF HYALURONIC ACID ON SCALP AND FOLLICLES -
ON THE IMPORTANCE OF PER OS TREATMENT FOR COMPLETE PHOTOPROTECTION OF THE SCALP
Products in this article:
Restax Woman 30cps
Restax Donna is a product with Agnocasto, designed and developed for female alopecia of childbearing age
TriVis Women's AGA Lotion
TRIVIS WOMEN'S LOTION is a topical hair lotion formulated for the purpose of nourishing hair bulbs, reducing inflammation and stimulating hair regrowth in patients with female alopecia.
